<unk>  is an endocrine-metabolic agent that is FDA approved for the treatment of stimulation of pancreatic<unk> ns to aid in the diagnosis of exocrine pancreas dysfunction, simulation of gastrin<unk> n to aid in the diagnosis of gastrinoma, facilitation of identification of the ampulla of Vater and the accessory papilla during endoscopic retrograde cholangiopancreatography (ERCP).   Common adverse reactions include nausea, flushing, abdominal pain, and vomiting.
Secretin human
Glucagon-like peptide-1
Histrelin
Somatrem
C-peptide
Ramogen
Bryostatin
Neuron doctrine